1. Sugar AM. Agents of mucormycosis and related species.
In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Bennett,
and Dolin:Principles and Practice of Infectious
Diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:2973-2984.
2. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and
outcome of zygomycosis: a review of 929 reported cases. Clin
Infect Dis. 2005;41(5):634-653.
3. Kwon-Chung KJ, Bennett JE. Mucormycosis. In: Kwon-Chung KJ,
Bennett JE, eds. Medical Mycology. Philadelphia,
PA: Lea & Febiger; 1992:524-559.
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycoses in human
disease. Clin Microbiol Rev. 2000;13(2):236-301.
5. Kline MW. Mucormycosis in children: review of the literature
and report of cases. Pediatr Infect Dis. 1985;4(6):672-676.
6. Neame P, Rayner D. Mucormycosis: a report on twenty-two cases.
Arch
Pathol. 1960;70:261-268.
[PubMed: 14426277]
7. Lewis LL, Hawkins HK, Edwards MS. Disseminated mucormycosis
in an infant with methylmalonicaciduria. Pediatr Infect
Dis J. 1990;9(11):851-854.
8. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis
in a neutropenic patient: successful treatment with amphotericin
B lipid complex and granulocyte colony-stimulating factor. Clin
Infect Dis. 1997;24(2):192-196.
9. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating
leukemia and lymphoma. Ann Intern Med. 1972;77(6):871-879.
10. Nash G, Foley FD, Goodwin MN Jr, Bruck HM, Greenwald KA,
Pruitt BA Jr. Fungal burn wound infection. JAMA. 1971;215(10):1664-1666.
11. Linder N, Keller N, Huri C, Kuint J, Goldshmidt-Reuven A,
Barzilai A. Primary cutaneous mucormycosis in a premature infant:
case report and review of the literature. Am J Perinatol. 1998;15(1):35-38.
12. Torack RM. Fungus infections associated with antibiotic
and steroid therapy.
Am J Med. 1957; 22(6):872-882.
[PubMed: 13424552]
13. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal
zygomycosis in a liver transplant recipient: case report and review
of zygomycosis in solid-organ transplant recipients. Clin
Infect Dis. 1995;20(3):617-620.
14. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology
and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin
Infect Dis. 2002;34(7):909-917.
15. Sane A, Manzi S, Perfect J, Herzberg AJ, Moore JO. Deferoxamine
treatment as a risk factor for Zygomycete infection. J Infect
Dis. 1989;159(1):151-152.
16. Oh D, Notrica D. Primary cutaneous mucormycosis in infants
and neonates: case report and review of the literature. J
Pediatr Surg. 2002;37(11):1607-1611.
17. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives
on mucormycosis: pathophysiology, presentation and management. Clin
Microbiol Rev. 2005;18(3):556-569.
18. Diamond RD, Clark RA. Damage to Aspergillus fumigatus and Rhizopus
oryzae hyphae by oxidative and nonoxidative microbicidal
products of human neutrophils in vitro. Infect Immunol. 1982;38(2):487-495.
19. Levitz SM, Selsted ME, Ganz T, Lehrer RI, Diamond RD. In
vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus
oryzae by rabbit neutrophil cationic peptides and bronchoalveolar
macrophages. J Infect Dis. 1986;154(3):483-489.
20. Boelaert JR, de Locht M, Van Cutsem J, et al. Mucormycosis
during deferoxamine therapy is a siderophore-mediated infection.
In vitro and in vivo animal studies. J ClinInvest. 1993;91(5):1979-1986.
21. Maartens G, Wood MJ. The clinical presentation and diagnosis
of invasive fungal infections. J Antimicrob Chemother. 1991;28(suppl
A):13-22.
22. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect
Dis Clin North Am. 2002;16(4):895-914.
23. Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla
F, Estrada-Bellmann I. Rhinocerebral and systemic mucormycosis.
Clinical experience with 36 cases. J Neurol Sci. 1996;143(1-2):19-30.
24. Lowe JT Jr, Hudson WR. Rhinocerebral phycomycosis and internal
carotid artery thrombosis. Arch Otolaryngol. 1975;101(2):100-103.
25. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KVI. Zygomycosis
in the 1990s in a tertiary-care cancer center. Clin Infect
Dis. 2000;30(6):851-856.
26. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the
last 30 years. Arch Intern Med. 1999;159(12):1301-1309.
27. Visser DH, van den Berg YLF, van Furth AM, et al. Diagnosis
and treatment of cutaneous zygomycosis. Pediatr Infect Dis
J. 2007;26(12):1165-1166.
28. Robertson AF, Joshi VV, Ellison DA, Cedars JC. Zygomycosis
in neonates. Pediatr Infect Dis J. 1997;16(8):812-815.
29. Craig NM, Lueder FL, Pensler JM, et al. Disseminated Rhizopus infection
in a premature infant. Pediatr Dermatol. 1994;11(4):346-350.
30. Mooney JE, Wanger A. Mucormycosis of the gastrointestinal
tract in children: report of a case and review of the literature. Pediatr
Infect Dis J. 1993;12(10):872-876.
31. Zaoutis TE, Roilides E, Chiou CC, et al. Zygomycosis in
children: a systematic review and analysis of reported cases. Pediatr
Infect Dis J. 2007;26(8):723-727.
32. Winkler S, Susani S, Willinger B, et al. Gastric mucormycosis
due to Rhizopus oryzae in a renal transplant recipient. J
Clin Microbiol. 1996;34(10): 2585-2587.
33. Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal
mucormycosis.
Br J Surg. 1991; 78(8):952-954.
[PubMed: 1913115]
34. Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated
zygomycosis: report of four cases and review. Rev Infect
Dis. 1989;11(5):741-754.
35. Whitecar JP Jr, Luna M, Bodey GP. Pseudomonas bacteremia
in patients with malignant diseases. Am J Med Sci. 1970;60(4):216-223.
36. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis.
The spectrum of the disease in 98 patients. Medicine. 1970;49(2):147-173.
37. van Burik JH, Hare RS, Solomon HF, Corrado ML, Kontoyiannis
DP. Posaconazole is effective as salvage therapy in zygomycosis:
a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):e61-e65.